4,425 Shares in CME Group Inc. $CME Bought by Strategic Investment Advisors MI

Key Points

• Strategic Investment Advisors MI initiated a CME Group position by purchasing 4,425 shares valued at approximately $1.3 million. Institutional investors collectively own 87.75% of the company.
• CME Group’s latest quarterly results exceeded expectations, with EPS of $2.99 versus the $2.91 consensus and revenue of $1.71 billion versus $1.68 billion expected. The company also maintains a $1.30 quarterly dividend, equivalent to a 1.9% yield.
• CME is pursuing growth through expanded retail access to futures and planned sports-related derivatives, while analysts remain divided: the stock carries a consensus “Hold” rating and an average price target of $291.81.

Strategic Investment Advisors MI bought a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 4,425 shares of the financial services provider's stock, valued at approximately $1,307,000.

Other institutional investors have also recently made changes to their positions in the company. Rehmann Capital Advisory Group increased its position in CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock valued at $243,000 after purchasing an additional 37 shares during the period. Asset Dedication LLC lifted its position in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC lifted its position in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider's stock worth $3,147,000 after purchasing an additional 37 shares during the period. Sovran Advisors LLC boosted its stake in shares of CME Group by 3.5% in the 4th quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider's stock valued at $305,000 after purchasing an additional 38 shares during the last quarter. Finally, Endowment Wealth Management Inc. boosted its stake in shares of CME Group by 4.4% in the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider's stock valued at $244,000 after purchasing an additional 38 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In other news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the business's stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company's stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company's stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Expanded retail access to futures: TradeStation is expanding its futures offering to include CME Group’s spot-quoted futures, potentially increasing participation, liquidity and transaction volume across CME’s markets. TradeStation Expands Futures Offering with CME Group Spot-Quoted Futures
• Positive Sentiment: Entry into sports-related derivatives: CME Group plans to launch cash-settled futures tied to sports performance indexes through a partnership with FutureSports. The initiative targets the roughly $650 billion global sports industry and could create a new source of trading and clearing revenue if it receives regulatory approval and attracts hedging demand. CME Group Targets $650 Billion Sports Industry With First Sports Index Futures
• Positive Sentiment: Recent earnings beat expectations: CME’s latest quarterly results exceeded consensus estimates, with earnings per share of $2.99 versus $2.91 expected and revenue of $1.71 billion versus $1.68 billion expected. Revenue increased year over year, reinforcing the company’s strong operating performance and high margins.
• Neutral Sentiment: Federal Reserve holds rates steady: The Fed kept its benchmark rate at 3.50%–3.75%, in line with expectations. The decision does not materially change CME’s outlook, though future rate uncertainty can support activity in interest-rate and other derivatives markets. Fed Holds Rates Between 3.50% and 3.75%
• Negative Sentiment: Minor earnings-estimate reduction: Erste Group Bank lowered its FY2027 EPS forecast to $12.91 from $12.94 and maintained a “Hold” rating. The small revision signals limited near-term upside from that analyst, though the estimate remains above the broader current-year consensus of $12.27.

CME Group Stock Performance

NASDAQ:CME opened at $267.36 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a fifty day moving average of $251.35 and a 200-day moving average of $281.15. The firm has a market capitalization of $96.88 billion, a P/E ratio of 22.68, a P/E/G ratio of 3.09 and a beta of 0.25.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group's revenue was up .8% on a year-over-year basis. During the same period in the prior year, the firm earned $2.96 earnings per share. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group's dividend payout ratio is currently 44.11%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research note on Thursday, July 23rd. UBS Group cut their price target on shares of CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a research report on Monday, July 6th. Weiss Ratings downgraded CME Group from a "buy (b)" rating to a "buy (b-)" rating in a report on Monday, July 13th. Piper Sandler lowered their price objective on CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research report on Wednesday, July 15th. Finally, Morgan Stanley boosted their price objective on CME Group from $324.00 to $330.00 and gave the company an "overweight" rating in a research note on Thursday, July 23rd. Eleven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of "Hold" and an average target price of $291.81.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.